Purchase Order 75F40125P00297

Award Date 9/29/25
Potential Completion Date 9/29/27
Potential Value $2.5M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase III Action
Primary Consortia Member
Not listed
Similar Awards
This is a $300,000 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Insilicom LLC, a woman-owned, minority-owned small business. The contract is for SBIR (Small Business Innovation Research) Topic 136 - INSILICOM, which involves developing advanced artificial intelligence and knowledge graph technologies for biomedical research and applications. The contract has no set-aside designation and is focused on creating...
This is a $9,671,431.00 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Safe Health Systems, Inc., a self-certified small disadvantaged business. The contract is to stimulate innovation in clinical evaluations and personalized medicine to improve product development and patient outcomes. The contract has a period of performance through March 27, 2026 and does not utilize a set-aside. No additional details about larger contract...
This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Integrated Laboratory Systems, LLC (ILS), a small business contractor, in the amount of $167,767.00. The contract is for a "Fragrance Study Titled, 'Evaluation of the Allergenicity and Sensitization Potential of Fragrance Substances Based on Survey of Scientific Literature.'" As a small business set-aside contract, ILS will conduct this research study on the allergenicity and...
This is a $3,677,482.71 firm fixed price contract awarded by the Food and Drug Administration (FDA) to Synensys, LLC, a Service-Disabled Veteran-Owned Small Business. The contract is for research and development to improve the reliability, interoperability, agility, and quality of laboratory data exchanges using system safety engineering and high reliability organization methods. This contract was awarded under a Broad Agency Announcement solicitation that sought proposals to advance...
This is a $109,853.26 firm fixed price purchase order awarded by the National Institute on Drug Abuse, a component of the U.S. Department of Health and Human Services, to Clarivate Analytics (Us) LLC. The contract provides a user license and subscription to the OFF-X (Translational Safety/Toxicology) and Cortellis Drug Discovery Intelligence software with the Biomarkers Module for the period of April 1, 2024 through March 31, 2025, with a total contract period of performance through March 31,...
The U.S. Food and Drug Administration (FDA) awarded a $108,661 firm fixed-price purchase order contract to Sayari Analytics, LLC, a small disadvantaged business located in Washington, D.C. The contract provides the FDA with access to Sayari's Graph internet database tool, which enables advanced data analytics capabilities such as risk assessment, sanctions monitoring, financial transaction analysis, and network mapping. This award is associated with a larger $45 million single-award Small...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to International Consulting Associates Inc. (ICA), an SBA-certified 8(a) small business. The $202,946.14 contract is for research to evaluate how the FDA's Center for Devices and Radiological Health (CDRH) assesses real-world evidence in regulatory submissions and identify best practices. ICA, a minority-owned small business, specializes in healthcare data...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Elsevier Inc., a leading global provider of scientific, technical, and medical information products and services. The contract, valued at $107,500.00, is for the provision of FAERS SOFTWARE - EMBASE, a proprietary medical research platform, over a 4-year period from May 2024 to April 2028. Elsevier holds two significant federal Indefinite Delivery Vehicles (IDVs) with the Library of Congress and the...
This is a $647,382.17 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a) minority-owned small disadvantaged business. The contract is for the identification of real-world evidence (RWE) used in premarket regulatory submissions. ICA has established itself as a key partner for federal health agencies, providing advanced data analytics, artificial intelligence, healthcare IT, and...
This is a $100,000.00 firm fixed price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to 3D Imaging Drug Design & Development LLC, a small business, to provide synthesis and delivery of DFNSH radiotracers to support the FDA's research efforts in imaging and drug development. The contract has a total small business set-aside designation and runs through October 31, 2023. 3D Imaging Drug Design & Development LLC is a limited liability company that...

This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Insilica LLC, a self-certified small disadvantaged business, for the FDA CLINICAL TRIALS.GOV REPORTING & ASD RESEARCH PROGRAM - SBIR III. The contract has a ceiling value of $2,500,000.00 and is part of the Small Business Innovation Research (SBIR) Phase III program, which provides funding to commercialize technologies developed under previous SBIR awards. The contract is for the period of September 29, 2025, through September 29, 2027. Insilica LLC is a limited liability company that specializes in developing advanced computational tools and platforms for environmental health, chemical safety, and biomedical research, with a focus on leveraging artificial intelligence, machine learning, and data science.

Generated 10/5/25, 12:46 AM